Skip to content
Recall Observatory FDA recall evidence

Drug product

buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, INDIA, NDC 16571-862-03

D-0222-2024

December 29, 2023

Class II

Product summary

Firm
Rising Pharma Holding, Inc.
Event
Event 93706
Status
Ongoing
Classification
Class II
Quantity
47,976 bottles
Official record key
drug-enforcement:D-0222-2024

Official wording

Reason: Presence of Foreign Tablets/Capsules

Code information: Lot #: BPA123098A, Exp. Date 06/2025

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Foreign Tablets